Which criteria support an IV to PO switch, and what steps ensure safety during the transition?

• A. Unstable clinical status
• B. Cost considerations
• C. Stable clinical status, adequate GI absorption, and comparable bioavailability
• D. Need for rapid onset

Answer: (C)

Switching from IV to PO works best when the patient is stable, can reliably absorb the oral formulation, and the oral form delivers similar systemic exposure to the IV form. Stability means the patient’s condition isn’t dependent on rapid IV action and there’s no ongoing need for immediate, high-peak drug levels to control infection or symptoms. If the patient is hemodynamically unstable, deteriorating, or requires rapid onset of effect, keeping IV is safer.

Adequate GI absorption is essential. The patient must be able to take medications by mouth, have a functioning gastrointestinal tract, and not be limited by vomiting, severe diarrhea, or malabsorption that would prevent the oral dose from achieving therapeutic levels.

Comparable bioavailability is key because not all drugs reach the same blood levels when given orally. Some medications have high oral bioavailability and can match IV exposure, while others have poor absorption or extensive first-pass metabolism that makes oral dosing unreliable. For a safe switch, the oral form must provide similar systemic exposure to the IV form, often requiring an established dose-conversion or confirmed guidelines.

In practice, safety during transition involves verifying the drug’s oral bioavailability and an appropriate dose-equivalence, confirming the patient can take PO and has no contraindications, and planning how to cover the period when moving from IV toward PO. If immediate effect is still needed, a brief overlap or a loading approach may be used to prevent subtherapeutic levels. Monitor the patient for clinical improvement and adverse effects, adjust as needed, and ensure clear communication with pharmacy and the care team so dosing, timing, and administration routes stay aligned. This approach helps maintain efficacy while reducing IV lines and potential infection risks.